Opinion

Video

Doublet Therapy With Venetoclax-Ibrutinib: Data and Guidelines

Panelists discuss the addition of doublet venetoclax-ibrutinib as a treatment option in ESMO guideline updates.

Video Player is loading.
Current Time 0:00
Duration 4:43
Loaded: 3.47%
Stream Type LIVE
Remaining Time 4:43
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected

Video content above is prompted by the following:

  • Briefly comment on the addition of doublet venetoclax-ibrutinib as a treatment option in ESMO guideline updates and highlight the underlying rationale and data supporting this approach.